Artificial intelligence predicts kidney cancer therapy response Updated on: May 18,2025 Artificial intelligence predicts kidney cancer therapy response Updated on:May 18,2025
Long visit in the ER? It's a good time to learn about cervical cancer screening Updated on: April 21,2025 Long visit in the ER? It's a good time to learn about cervical cancer screening Updated on:April 21,2025
Scientists develop a foundational map of tumor cells for personalized brain cancer treatments Updated on: July 15,2025 Scientists develop a foundational map of tumor cells for personalized brain cancer treatments Updated on:July 15,2025
Vitamin D can increase likelihood that breast cancer will disappear with chemotherapy Updated on: July 11,2025 Vitamin D can increase likelihood that breast cancer will disappear with chemotherapy Updated on:July 11,2025
How bacteria in aging guts can elevate risk of leukemia and perhaps more Updated on: May 18,2025 How bacteria in aging guts can elevate risk of leukemia and perhaps more Updated on:May 18,2025
Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs Updated on: March 27,2025 Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs Updated on:March 27,2025
Geroscience: Rethinking how medicine can approach aging Updated on: September 04,2025 Geroscience: Rethinking how medicine can approach aging Updated on:September 04,2025
Mathematical model reveals surprising light levels in the womb, reshaping fetal vision understanding Updated on: March 29,2025 Mathematical model reveals surprising light levels in the womb, reshaping fetal vision understanding Updated on:March 29,2025
Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer Updated on: September 30,2025 Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer Updated on:September 30,2025
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC Updated on: September 30,2025 Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC Updated on:September 30,2025